Detection of antinuclear antibodies: Added value of solid phase assay?

Annals of the Rheumatic Diseases

Volumn 73, Issue 3, 2014, Pages

  Bossuyt, Xavier ^a,b   Fieuws, Steffen ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c KU LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODIES; AUTOIMMUNE DISEASES; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLERGY AND IMMUNOLOGY; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; HUMANS; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 84893781522     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204793     Document Type: Letter

References (5)

1. Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73:17-23.
2. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420-2.
3. Op De Beeck K, Vermeersch P, Verschueren P, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011;10:801-8.
4. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997;40:1601-11. (Pubitemid 27426153)
5. Op De Beéck K, Vermeersch P, Verschueren P, et al. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev 2012;12:137-43.